Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)

19.89
Delayed Data
As of Jun 18
 -0.06 / -0.30%
Today’s Change
6.50
Today|||52-Week Range
23.50
+4.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.9B

Company Description

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

Contact Information

Spectrum Pharmaceuticals, Inc.
11500 South Eastern Avenue
Henderson Nevada 89052
P:(702) 835-6300
Investor Relations:

Employees

Shareholders

Individual stakeholders6.04%
Mutual fund holders43.17%
Other institutional39.76%

Top Executives

Joseph W. TurgeonPresident, Chief Executive Officer & Director
Thomas J. RigaExecutive VP, Chief Operating & Commercial Officer
Kurt A. GustafsonChief Financial Officer & Executive Vice President
Guru ReddyVice President-Preclinical Research & Development
Keith M. McGahanChief Legal Officer & Senior Vice President